Participant flow54

How many started, completed or left each group, period by period.

1 to 20 of 54

Period	Milestone	Group	Participants
Primary Treatment Phase	STARTED	Xelox	317
Primary Treatment Phase	STARTED	Folfox-4	317
Primary Treatment Phase	STARTED	Xelox+P	350
Primary Treatment Phase	STARTED	Folfox-4+P	351
Primary Treatment Phase	STARTED	Xelox+BV	350
Primary Treatment Phase	STARTED	Folfox-4+BV	349
Primary Treatment Phase	COMPLETED	Xelox	22
Primary Treatment Phase	COMPLETED	Folfox-4	15
Primary Treatment Phase	COMPLETED	Xelox+P	36
Primary Treatment Phase	COMPLETED	Folfox-4+P	31
Primary Treatment Phase	COMPLETED	Xelox+BV	48
Primary Treatment Phase	COMPLETED	Folfox-4+BV	48
Primary Treatment Phase	NOT COMPLETED	Xelox	295
Primary Treatment Phase	NOT COMPLETED	Folfox-4	302
Primary Treatment Phase	NOT COMPLETED	Xelox+P	314
Primary Treatment Phase	NOT COMPLETED	Folfox-4+P	320
Primary Treatment Phase	NOT COMPLETED	Xelox+BV	302
Primary Treatment Phase	NOT COMPLETED	Folfox-4+BV	301
Post-study Treatment Phase	STARTED	Xelox	8
Post-study Treatment Phase	STARTED	Folfox-4	13

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00069095/flow